Back to Journals » Breast Cancer: Targets and Therapy » Volume 4

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

Total article views   HTML views PDF downloads Totals
14,205 Dovepress* 12,508+ 3,133 15,641
PubMed Central* 1,697 1,440 3,137
Totals 14,205 4,573 18,778
*Since 27 August 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar